15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27178386	1	Drug discovery strategies to outer membrane targets in Gram-negative pathogens.	Astrazeneca
12086497	64	Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.	Chiron
30226381	16	Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.	Novartis Institutes For Biomedical Research
28302397	73	Structure-based discovery of LpxC inhibitors.	Cubist Pharmaceuticals
25408833	21	Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.	Astrazeneca
22257165	50	Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.	Pfizer
22401863	30	Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.	Pfizer
28549219	30	Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.	Novartis Institutes For Biomedical Research
23051174	16	In vivo and in vitro effect of androstene derivatives as 5a-reductase type 1 enzyme inhibitors.	National University of Mexico City
15202489	50	Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzyme.	Saarland University